vs
Side-by-side financial comparison of CSP INC (CSPI) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
CSP INC is the larger business by last-quarter revenue ($12.0M vs $9.2M, roughly 1.3× Foghorn Therapeutics Inc.). CSP INC runs the higher net margin — 0.8% vs -234.3%, a 235.0% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -23.2%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -6.3%).
CSP Inc. is a U.S.-based technology firm offering cybersecurity solutions, managed IT services, high-performance computing systems, and IT consulting support. It serves enterprises across healthcare, finance, manufacturing, and public sectors in North America and select global markets.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
CSPI vs FHTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.0M | $9.2M |
| Net Profit | $91.0K | $-21.7M |
| Gross Margin | 39.3% | — |
| Operating Margin | -0.9% | -258.2% |
| Net Margin | 0.8% | -234.3% |
| Revenue YoY | -23.2% | 223.8% |
| Net Profit YoY | -80.7% | -11.1% |
| EPS (diluted) | $0.01 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.0M | $9.2M | ||
| Q3 25 | $14.5M | $8.2M | ||
| Q2 25 | $15.4M | $7.6M | ||
| Q1 25 | $13.1M | $6.0M | ||
| Q4 24 | $15.7M | $2.9M | ||
| Q3 24 | $13.0M | $7.8M | ||
| Q2 24 | $13.1M | $6.9M | ||
| Q1 24 | $13.7M | $5.0M |
| Q4 25 | $91.0K | $-21.7M | ||
| Q3 25 | $-191.0K | $-15.8M | ||
| Q2 25 | $-264.0K | $-17.9M | ||
| Q1 25 | $-108.0K | $-18.8M | ||
| Q4 24 | $472.0K | $-19.5M | ||
| Q3 24 | $-1.7M | $-19.1M | ||
| Q2 24 | $-185.0K | $-23.0M | ||
| Q1 24 | $1.6M | $-25.0M |
| Q4 25 | 39.3% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 28.8% | — | ||
| Q1 25 | 32.0% | — | ||
| Q4 24 | 29.1% | — | ||
| Q3 24 | 28.4% | — | ||
| Q2 24 | 35.0% | — | ||
| Q1 24 | 47.3% | — |
| Q4 25 | -0.9% | -258.2% | ||
| Q3 25 | -3.7% | -226.9% | ||
| Q2 25 | -7.9% | -279.2% | ||
| Q1 25 | -7.6% | -385.0% | ||
| Q4 24 | -2.3% | -840.5% | ||
| Q3 24 | -15.7% | -305.5% | ||
| Q2 24 | -5.5% | -386.6% | ||
| Q1 24 | 9.0% | -558.3% |
| Q4 25 | 0.8% | -234.3% | ||
| Q3 25 | -1.3% | -194.4% | ||
| Q2 25 | -1.7% | -237.3% | ||
| Q1 25 | -0.8% | -316.4% | ||
| Q4 24 | 3.0% | -682.9% | ||
| Q3 24 | -12.7% | -244.9% | ||
| Q2 24 | -1.4% | -333.6% | ||
| Q1 24 | 11.6% | -495.4% |
| Q4 25 | $0.01 | $-0.35 | ||
| Q3 25 | $-0.02 | $-0.25 | ||
| Q2 25 | $-0.03 | $-0.28 | ||
| Q1 25 | $-0.01 | $-0.30 | ||
| Q4 24 | $0.05 | $-0.23 | ||
| Q3 24 | $-0.17 | $-0.31 | ||
| Q2 24 | $-0.02 | $-0.45 | ||
| Q1 24 | $0.16 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.9M | $80.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $44.8M | $-108.5M |
| Total Assets | $69.2M | $198.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.9M | $80.9M | ||
| Q3 25 | $27.4M | $89.3M | ||
| Q2 25 | $26.3M | $72.6M | ||
| Q1 25 | $29.5M | $61.0M | ||
| Q4 24 | $30.7M | $55.5M | ||
| Q3 24 | $30.6M | $57.7M | ||
| Q2 24 | $28.9M | $138.9M | ||
| Q1 24 | $27.1M | $79.3M |
| Q4 25 | $44.8M | $-108.5M | ||
| Q3 25 | $44.6M | $-89.7M | ||
| Q2 25 | $47.5M | $-76.7M | ||
| Q1 25 | $47.5M | $-61.7M | ||
| Q4 24 | $47.5M | $-45.5M | ||
| Q3 24 | $47.3M | $-28.3M | ||
| Q2 24 | $48.1M | $-14.3M | ||
| Q1 24 | $48.2M | $-97.5M |
| Q4 25 | $69.2M | $198.1M | ||
| Q3 25 | $71.2M | $205.0M | ||
| Q2 25 | $66.8M | $226.2M | ||
| Q1 25 | $67.1M | $258.7M | ||
| Q4 24 | $67.5M | $284.0M | ||
| Q3 24 | $69.4M | $308.4M | ||
| Q2 24 | $66.8M | $328.6M | ||
| Q1 24 | $64.2M | $255.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $-22.3M |
| Free Cash FlowOCF − Capex | $-3.0M | — |
| FCF MarginFCF / Revenue | -25.1% | — |
| Capex IntensityCapex / Revenue | 0.9% | 0.0% |
| Cash ConversionOCF / Net Profit | -32.04× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-2.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $-22.3M | ||
| Q3 25 | $1.9M | $-18.9M | ||
| Q2 25 | $-3.3M | $-21.0M | ||
| Q1 25 | $1.9M | $-24.0M | ||
| Q4 24 | $1.7M | $-24.5M | ||
| Q3 24 | $-1.5M | $-21.0M | ||
| Q2 24 | $2.4M | $-25.5M | ||
| Q1 24 | $1.7M | $-29.3M |
| Q4 25 | $-3.0M | — | ||
| Q3 25 | $1.7M | — | ||
| Q2 25 | $-3.3M | $-21.0M | ||
| Q1 25 | $1.9M | $-24.0M | ||
| Q4 24 | $1.7M | $-25.0M | ||
| Q3 24 | $-1.5M | $-21.3M | ||
| Q2 24 | $2.4M | $-25.6M | ||
| Q1 24 | $1.6M | $-29.4M |
| Q4 25 | -25.1% | — | ||
| Q3 25 | 11.5% | — | ||
| Q2 25 | -21.7% | -278.2% | ||
| Q1 25 | 14.5% | -403.2% | ||
| Q4 24 | 10.8% | -875.3% | ||
| Q3 24 | -11.7% | -273.0% | ||
| Q2 24 | 17.9% | -371.0% | ||
| Q1 24 | 11.9% | -583.1% |
| Q4 25 | 0.9% | 0.0% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 0.4% | 0.3% | ||
| Q1 25 | 0.1% | 0.5% | ||
| Q4 24 | 0.3% | 16.8% | ||
| Q3 24 | 0.1% | 4.0% | ||
| Q2 24 | 0.3% | 0.2% | ||
| Q1 24 | 0.1% | 2.0% |
| Q4 25 | -32.04× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.69× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSPI
| Products | $6.7M | 56% |
| Services | $5.3M | 44% |
FHTX
Segment breakdown not available.
